Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice (Q34308238)

1 August 2017

title

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice (English)

1 reference

1 August 2017

1 reference

1

Nosratola D Vaziri

1 reference

1 August 2017

Hyun Ju Kim

2

1 reference

1 August 2017

Hamid Moradi

3

1 reference

1 August 2017

Farbod Farmand

4

1 reference

1 August 2017

Kaveh Navab

5

1 reference

1 August 2017

Mohamad Navab

6

1 reference

1 August 2017

Susan Hama

7

1 reference

1 August 2017

Alan M Fogelman

8

1 reference

1 August 2017

Yasmir Quiroz

9

1 reference

1 August 2017

Bernardo Rodriguez-Iturbe

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

20 May 2010

1 reference

Nephrology Dialysis Transplantation

1 August 2017

published in

1 reference

1 August 2017

volume

25

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

3525-3534

1 reference

Causes of dysregulation of lipid metabolism in chronic renal failure

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

The effect of lipoproteins on the development and progression of renal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Mouse models for atherosclerosis and pharmaceutical modifiers.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Dyslipidemia and the progression of renal disease in chronic renal failure patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Apolipoprotein E: far more than a lipid transport protein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

The role of lipids in renal disease: future challenges.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Lipid abnormalities in renal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ274

Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2980997

Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors

28 October 2018

1 reference

12 December 2020

Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species

1 reference

12 December 2020

Lipid abnormalities in renal disease

1 reference

12 December 2020

Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages

1 reference

12 December 2020

Renal injury in apolipoprotein E-deficient mice

1 reference

12 December 2020

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency

1 reference

12 December 2020

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFQ274

1 reference

1 August 2017

1 reference

1 August 2017

1 reference